These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24562771)

  • 1. Dermcidin expression is associated with disease progression and survival among breast cancer patients.
    Brauer HA; D'Arcy M; Libby TE; Thompson HJ; Yasui YY; Hamajima N; Li CI; Troester MA; Lampe PD
    Breast Cancer Res Treat; 2014 Apr; 144(2):299-306. PubMed ID: 24562771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.
    Bancovik J; Moreira DF; Carrasco D; Yao J; Porter D; Moura R; Camargo A; Fontes-Oliveira CC; Malpartida MG; Carambula S; Vannier E; Strauss BE; Wakamatsu A; Alves VA; Logullo AF; Soares FA; Polyak K; Belizário JE
    BMC Cancer; 2015 Feb; 15():70. PubMed ID: 25879571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in MNU and DMBA-induced mammary tumors in female rats.
    Alvarado A; Lopes AC; Faustino-Rocha AI; Cabrita AMS; Ferreira R; Oliveira PA; Colaço B
    Pathol Res Pract; 2017 May; 213(5):441-446. PubMed ID: 28285967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tn antigen is a pre-cancerous biomarker in breast tissue and serum in n-nitrosomethylurea-induced rat mammary carcinogenesis.
    Babino A; Oppezzo P; Bianco S; Barrios E; Berois N; Navarrete H; Osinaga E
    Int J Cancer; 2000 Jun; 86(6):753-9. PubMed ID: 10842187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
    Ting AY; Kimler BF; Fabian CJ; Petroff BK
    Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief communication, P53 accumulation in N-methyl-N-nitrosourea-induced rat mammary tumors.
    Crist KA; Fuller RD; Chaudhuri B; Chaudhuri P; You M
    Toxicol Pathol; 1996; 24(3):370-5. PubMed ID: 8736394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
    Green A; Shilkaitis A; Christov K
    Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
    Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
    J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MNU-induced rat mammary carcinomas: immunohistology and estrogen receptor expression.
    Soares-Maia R; Faustino-Rocha A; Teixeira-Guedes C; Pinho-Oliveira J; Talhada D; Rema A; Faria F; Ginja M; Ferreira R; da Costa R; Oliveira PA; Lopes C
    J Environ Pathol Toxicol Oncol; 2013; 32(2):157-63. PubMed ID: 24099429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
    Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea.
    Thompson HJ; McGinley JN; Rothhammer K; Singh M
    Carcinogenesis; 1995 Oct; 16(10):2407-11. PubMed ID: 7586143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characterization of mammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors.
    Costa I; Solanas M; Escrich E
    Arch Pathol Lab Med; 2002 Aug; 126(8):915-27. PubMed ID: 12171489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro measures used to predict anticancer activity of apple cultivars and their comparison to outcomes from a rat model of experimentally induced breast cancer.
    Thompson MD; Stushnoff C; McGinley JN; Thompson HJ
    Nutr Cancer; 2009; 61(4):510-7. PubMed ID: 19838923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.
    Li J; Orlandi R; White CN; Rosenzweig J; Zhao J; Seregni E; Morelli D; Yu Y; Meng XY; Zhang Z; Davidson NE; Fung ET; Chan DW
    Clin Chem; 2005 Dec; 51(12):2229-35. PubMed ID: 16223889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effects of postnatal exposure to a mixture of aryl hydrocarbon-receptor agonists on the development of methylnitrosourea-induced mammary tumors in sprague-dawley rats.
    Desaulniers D; Leingartner K; Musicki B; Cole J; Li M; Charbonneau M; Tsang BK
    J Toxicol Environ Health A; 2004 Sep; 67(18):1457-75. PubMed ID: 15371232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.